US · Regulatory authority
FDA regulatory signals
RegSig automatically extracts and normalizes regulatory signals from FDA—mapping updates on Nutrition Claims, Country of Origin, Additives directly to product portfolios across 7 jurisdictions.
- 10 active signals
- US
- 6 topics
10
Active signals
6
Topics
7
Jurisdictions
US
Region
How RegSig covers FDA
RegSig's AI-native pipeline continuously ingests FDA publications, extracts regulatory actions, and normalizes them into scored signals with topic classification, time horizon, and jurisdiction context. Each signal is linked to source evidence and mapped against product portfolios so compliance teams can assess exposure without manual triage.
Representative signals from FDA
Compliance Enforcement on Nutrition Labeling and Point-of-purchase Display for Label and Claims
Long-termNutrition Claims
What changed: FSIS adopted Nutrition Labeling and Point-of-Purchase Display Requirements for nutrition-labeled SKUs in Global, updating what must be substantiated on pack and in supporting records.
FDA Enforcement Focus on Allergen Declaration Expectations for Compliance Remediation
Near-termCountry of Origin
What changed: FSIS adopted allergen declaration expectations for allergen-containing products in Global, updating what must be substantiated on pack and in supporting records.
Enforcement Signal on Nutrition Labeling and Point-of-purchase Disclos for Label and Claims
Near-termAdditives
What changed: FSIS adopted nutrition labeling and point-of-purchase disclosure rules for allergen-containing products in Global, updating what must be substantiated on pack and in supporting records.
Compliance Enforcement on Nutrition Labeling and Point-of-purchase Disclos for Marketed Product Labels
Near-termHealth Claims
What changed: FDA adopted nutrition labeling and point-of-purchase disclosure rules for claim-bearing retail packs in Global, updating what must be substantiated on pack and in supporting records.
Federal Proposal on Allergen Declaration Expectations for FDA-regulated Labels
Near-termAllergen Labeling
What changed: Regulators proposed allergen declaration expectations for allergen-containing products, updating what must be substantiated on pack and in supporting records.
Enforcement Signal on Ingredient Disclosure Labeling Requirements for Compliance Remediation
Near-termIngredient Disclosure
What changed: Regulators proposed Ingredient Disclosure labeling requirements, updating what must be substantiated on pack and in supporting records.
Enforcement Signal on Allergen Labeling Labeling Requirements for Marketed Product Labels
Near-termAllergen Labeling
What changed: Regulators proposed Allergen Labeling labeling requirements for ready-to-eat products, updating what must be substantiated on pack and in supporting records.
Federal Proposal on Health Claims Labeling Requirements for FDA-regulated Labels
Near-termHealth Claims
What changed: Regulators proposed Health Claims labeling requirements, updating what must be substantiated on pack and in supporting records.
Compliance Enforcement on Allergen Labeling Labeling Requirements for Compliance Remediation
Near-termAllergen Labeling
What changed: Regulators revised Allergen Labeling labeling requirements, updating what must be substantiated on pack and in supporting records.
FDA Proposed Shift on Health Claims Labeling Requirements for Us Market Labels
Near-termHealth Claims
What changed: Regulators proposed Health Claims labeling requirements, updating what must be substantiated on pack and in supporting records.
Full signal detail and portfolio mapping available after registration.
Regulatory topics from FDA
Jurisdictions in FDA signals
Explore more authorities
Individual access
Monitor FDA signals signals in your portfolio
RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.